While we continue to be focused on introducing Clarifi ASD to physicians for clinical use with their patients, our research team has been very active in expanding the utility of Clarifi ASD, as well as our other efforts in the areas of Parkinson's disease, concussion, and anorexia nervosa.

In this update, our VP of Research, Samantha DeVita, talks about the current research efforts to expand the utility of Clarifi ASD. These efforts include increasing the diversity of our study population, looking at longitudinal molecular changes associated with reductions in symptoms due to evidence-based therapy, and examining RNA during the first four months after birth when the benefits of breastfeeding are conferred. We look forward to sharing the results of these exciting research projects as they become available.

For more information about the investment, including information on the risks involved, please read our offering circular and supplement found here.